Company Filing History:
2 out of 2 
2 out of 1,743 
2 out of 99 
Years Active: 2016-2017
Title: Paul Amouyal: Innovator in Medical Research
Introduction
Paul Amouyal is a notable inventor based in Sèvres, France. He has made significant contributions to the field of medical research, particularly in the areas of insulin resistance and cancer treatment. With a total of 2 patents, his work has the potential to impact many lives.
Latest Patents
Amouyal's latest patents include a composition that utilizes the HIP/PAP protein or its derivatives for treating insulin resistance. This invention focuses on the use of the HIP/PAP protein in non-insulin dependent subjects to prevent or treat insulin resistance. Additionally, he has developed a patent concerning the HIP/PAP protein or its derivatives for use in treating or managing cancer, specifically targeting solid tumors.
Career Highlights
Throughout his career, Paul Amouyal has worked with prominent organizations such as Alfact Innovation and the Institut National de la Santé et de la Recherche Médicale. His experience in these institutions has allowed him to advance his research and contribute to significant medical advancements.
Collaborations
Amouyal has collaborated with esteemed colleagues, including Marion Darnaud and Laure Jamot. These partnerships have fostered a collaborative environment that enhances the innovation process.
Conclusion
Paul Amouyal's contributions to medical research through his patents and collaborations highlight his commitment to advancing healthcare solutions. His work in treating insulin resistance and cancer showcases the importance of innovation in improving patient outcomes.